Adisyn Ltd secures $10M in a heavily oversubscribed placement, driving innovation in graphene-enhanced semiconductors and solidifying its position as an industry leader. #Innovation #Semiconductors #AdisynLtd
Adisyn Ltd secures $10M in a heavily oversubscribed placement, driving innovation in graphene-enhanced semiconductors and solidifying its position as an industry leader. #Innovation #Semiconductors #AdisynLtd
Kevin Crofton, a globally recognised leader in the semiconductor industry, to join Adisyn Ltd as Non-Executive Director.
Kevin Crofton, a globally recognised leader in the semiconductor industry, to join Adisyn Ltd as Non-Executive Director.
@memphasys RoXsta™ system is transforming oxidative stress diagnostics. Recently featured in Antioxidants, it’s revolutionizing fertility treatments, disease management, and applications in agriculture and cosmetics. #RoXsta #Innovation #Healthcare #O
@memphasys RoXsta™ system is transforming oxidative stress diagnostics. Recently featured in Antioxidants, it’s revolutionizing fertility treatments, disease management, and applications in agriculture and cosmetics. #RoXsta #Innovation #Healthcare #OxidativeStress $MEM https://hubs.li/Q0335j-P0
Memphasys has launched a bovine study using the RoXsta™ antioxidant system to explore links between oxidative stress and reproductive performance. Blood analysis begins January, with results expected February 2025. #Memphasys #RoXsta #AgTech #BovineStud
Memphasys has launched a bovine study using the RoXsta™ antioxidant system to explore links between oxidative stress and reproductive performance. Blood analysis begins January, with results expected February 2025. #Memphasys #RoXsta #AgTech #BovineStudy
Memphasys Reproductive Biotechnology has signed a Letter of Intent with Heranova Lifesciences HK Limited to launch and distribute the FelixTM System in Greater China, marking a significant expansion into one of the largest markets for assisted reproducti
Memphasys Reproductive Biotechnology has signed a Letter of Intent with Heranova Lifesciences HK Limited to launch and distribute the FelixTM System in Greater China, marking a significant expansion into one of the largest markets for assisted reproductive treatments.
MTM Critical Metals' Flash Joule Heating technology slashes impurities by 48%, boosts REE concentration by 50%, and redefines sustainability in the industry. 🌍⚡ With a streamlined process and greener approach, we're paving the way for the future of c
MTM Critical Metals' Flash Joule Heating technology slashes impurities by 48%, boosts REE concentration by 50%, and redefines sustainability in the industry. 🌍⚡ With a streamlined process and greener approach, we're paving the way for the future of critical minerals. #Innovation #Sustainability #RareEarths
progressing to the future of fertility! The Felix™ System's clinical trial is 95% complete, If current recruitment rates are sustained trial completion is expected by EOY. 🌍 Paving the way for global market entry, starting with Europe, and revolution
progressing to the future of fertility! The Felix™ System's clinical trial is 95% complete, If current recruitment rates are sustained trial completion is expected by EOY. 🌍 Paving the way for global market entry, starting with Europe, and revolutionizing sperm selection for fertility clinics worldwide. 🌱 #Innovation #FertilityTech #FelixSystem"
ASX Micro-cap poised to hit massive milestones
🚀 Memphasys Limited (ASX: MEM) is advancing reproductive biotech! 🚀
With the Felix™ System nearing clinical trial completion, expanded market reach in Japan, and the innovative RoXsta™ assay system, Memphasys is setting the stage for significant growth.
With strategic discussions underway and funding secured, could a re-rate be on the horizon? 📈
Learn more about the company and its unique investment proposition here: https://www.memphasys.com
ASX Micro-cap poised to hit massive milestones
ASX Biotech microcap poised for re-rate
ABx has achieved a breakthrough 97% fluorine recovery rate, demonstrating the success of ALCORE's advanced reactor design.
ABx has achieved a breakthrough 97% fluorine recovery rate, demonstrating the success of ALCORE's advanced reactor design.
Little Green Pharma (ASX: LGP) is leading the charge in the medicinal cannabis sector! $LGP has (for Sept quarter) reported record-breaking revenue of $10.2 million, up 40% from the prior quarter, and a 60% surge year-on-year.
Little Green Pharma (ASX: LGP) is leading the charge in the medicinal cannabis sector! $LGP has (for Sept quarter) reported record-breaking revenue of $10.2 million, up 40% from the prior quarter, and a 60% surge year-on-year.